Linked Life Data

6387569

Source:http://linkedlifedata.com/resource/pubmed/id/6387569

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6387569rdf:typepubmed:Citationlld:pubmed
pubmed-article:6387569lifeskim:mentionsumls-concept:C0027599lld:lifeskim
pubmed-article:6387569lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:6387569lifeskim:mentionsumls-concept:C1533613lld:lifeskim
pubmed-article:6387569lifeskim:mentionsumls-concept:C0392247lld:lifeskim
pubmed-article:6387569lifeskim:mentionsumls-concept:C1609285lld:lifeskim
pubmed-article:6387569pubmed:issue9lld:pubmed
pubmed-article:6387569pubmed:dateCreated1984-12-19lld:pubmed
pubmed-article:6387569pubmed:abstractTextA prospective short-term clinical study evaluated argon and Q-switched neodymium:YAG laser iridotomies in 40 eyes of 20 patients with primary chronic angle-closure glaucoma. All patients had bilateral iridotomies with one eye randomly assigned to argon laser and the fellow eye to neodymium:YAG laser therapy. In all eyes a patent iridotomy was created in one treatment session. A mean of 12 +/- 11 and 0.033 +/- 0.025 J were needed for iridotomy formation in argon and neodymium:YAG treated eyes respectively. No neodymium:YAG and six (30%) argon iridotomies had marked closure requiring retreatment. Immediate postoperative intraocular pressure elevation greater than 10 mmHg was seen in seven (35%) argon and six (30%) neodymium:YAG-treated eyes. Nine (45%) eyes treated with the neodymium:YAG laser had bleeding from the iridotomy site. No acute lens damage was found in the neodymium:YAG eyes while seven (35%) lenses in the argon group had focal opacities. Seven (35%) neodymium:YAG and five (25%) argon treated eyes had focal nonprogressive corneal opacities above the iridotomy site. Specular microscopy showed a significant central corneal endothelial loss in argon laser treated eyes. No eyes had detectable retinal damage.lld:pubmed
pubmed-article:6387569pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6387569pubmed:languageenglld:pubmed
pubmed-article:6387569pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6387569pubmed:citationSubsetIMlld:pubmed
pubmed-article:6387569pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6387569pubmed:statusMEDLINElld:pubmed
pubmed-article:6387569pubmed:monthSeplld:pubmed
pubmed-article:6387569pubmed:issn0161-6420lld:pubmed
pubmed-article:6387569pubmed:authorpubmed-author:PollackI PIPlld:pubmed
pubmed-article:6387569pubmed:authorpubmed-author:RobinA LALlld:pubmed
pubmed-article:6387569pubmed:issnTypePrintlld:pubmed
pubmed-article:6387569pubmed:volume91lld:pubmed
pubmed-article:6387569pubmed:ownerNLMlld:pubmed
pubmed-article:6387569pubmed:authorsCompleteYlld:pubmed
pubmed-article:6387569pubmed:pagination1011-6lld:pubmed
pubmed-article:6387569pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:meshHeadingpubmed-meshheading:6387569-...lld:pubmed
pubmed-article:6387569pubmed:year1984lld:pubmed
pubmed-article:6387569pubmed:articleTitleA comparison of neodymium: YAG and argon laser iridotomies.lld:pubmed
pubmed-article:6387569pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6387569pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:6387569pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6387569pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6387569pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6387569lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6387569lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6387569lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6387569lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6387569lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6387569lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6387569lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6387569lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6387569lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6387569lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6387569lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6387569lld:pubmed